Peptide ·

Limited evidence

Leuphasyl

INCI: Pentapeptide-18

What is it?

A neuromodulatory ("Botox-like") peptide marketed under the trade name Leuphasyl, studied for reducing expression-line wrinkles by inhibiting neurotransmitter release at the neuromuscular junction, distinct from Acetyl Octapeptide-3.

What does it do?

According to PubMed, a 2026 computational and spectroscopic study used molecular docking and dynamics simulations to characterize Pentapeptide-18's binding to several molecular pathways implicated in skin aging (TGF-beta, TNF-alpha, MAPK, PI3K/AKT, NF-kB), providing mechanistic support for its reported ability to reduce wrinkle formation and improve skin hydration, elasticity and texture (DOI: https://doi.org/10.1016/j.compbiolchem.2026.108952). This is a computational/structural characterization study rather than a human clinical trial; no dedicated RCT for this specific peptide was found in this search.

Check this ingredient with another — compatibility notes for every pair
See how this fits your skin — try SKYNN AI, free

Sources

Important disclaimer

This page provides general skincare information and is not medical advice, diagnosis or treatment. Ingredient interactions and evidence summaries reflect published, cited sources — not a personal assessment of your skin. For medical skin conditions, rashes, pregnancy/lactation questions or persistent concerns, please consult a licensed dermatologist or HPCSA-registered practitioner.